BioCryst Pharmaceuticals
BCRX
#4608
Rank
ยฃ1.28 B
Marketcap
ยฃ6.21
Share price
2.39%
Change (1 day)
0.80%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ0.72 B

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are ยฃ0.72 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.76 B9.34%
2022-12-31ยฃ0.69 B35.92%
2021-12-31ยฃ0.51 B98.09%
2020-12-31ยฃ0.25 B151.11%
2019-12-31ยฃ0.10 B34.98%
2018-12-31ยฃ76.49 M9.41%
2017-12-31ยฃ69.91 M-2.26%
2016-12-31ยฃ71.53 M42.19%
2015-12-31ยฃ50.31 M27.89%
2014-12-31ยฃ39.33 M29.96%
2013-12-31ยฃ30.27 M-15.45%
2012-12-31ยฃ35.8 M-17.44%
2011-12-31ยฃ43.36 M51.82%
2010-12-31ยฃ28.56 M-18.02%
2009-12-31ยฃ34.83 M31.28%
2008-12-31ยฃ26.53 M-31.9%
2007-12-31ยฃ38.97 M61.28%
2006-12-31ยฃ24.16 M2.11%
2005-12-31ยฃ23.66 M1348.16%
2004-12-31ยฃ1.63 M75.8%
2003-12-31ยฃ0.92 M27.16%
2002-12-31ยฃ0.73 M-53.57%
2001-12-31ยฃ1.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.66 B-7.64%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.78 B 147.59%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.61 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.71 B 137.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ26.95 B 3,632.18%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ24.32 M-96.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ42.70 B 5,811.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.85 B 18.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.88 M-98.35%๐Ÿ‡บ๐Ÿ‡ธ USA